Aetna provides health care, dental, pharmacy, group life, disability, and long term care benefits. The company offers a range of products and services under three categories: health care, group insurance, and large case pensions. Strong market position in the US healthcare combined with wide and deep product portfolio is enhancing customer base. However, significant reforms in the US healthcare industry, high dependence on outsourced vendors and increasing operating expenses, are likely to affect the company’s margins. The completion of a SWOT analysis of Aetna revealed that the company has several strength that will help usher the company into their next phase.
However, there was a significant market potential of the product for smaller capacity tanks. By producing a product that could satisfy the needs of customers, who required a convenient and safe-to-use biocide for their smaller reservoirs, Rohm and Haas had an opportunity to expand the maintenance market. In order to tap this huge segment and increase sales the company had to re-evaluate the marketing strategy for Kathon MWX and enhance its allocation for distribution and marketing expenditures. It was also important to consider the necessity to communicate the safety in usage and cost-effectiveness to the end users. Taking into account the limited budget and the nature of existing distribution channels the marketing director had to review her marketing plan and find out new ways to accomplish the company’s objectives.
Competition a. Primary Competition The beverage industry is constantly competing with many of the new drinks that have been introduced into the market. According to Mintel, competition has been affected by price, interchangeable drink options, and by the companies’ acquisition of small and new beverage companies. The market for vitamin-enhanced water compete with new product innovation driven by health and wellness, and most products now offer almost the same benefits as the vitamin water products such as fruity flavored, antioxidants, minerals etc. For this reason, it is believed that the primary competition for Vitamin water is Gatorade, Propel, Powerade, and Snapple.
The second solution to raising prescription prices is passing of The Affordable Prescription Drug Act (APDA). APDA strikes a balance between reducing prices to make essential drugs more available and affordable. The legislation works with pharmaceutical companies to ensure profits are reinvested into research and development of new medicines. APDA increases competition in the pharmaceutical market, thus reducing the price of prescription drugs, while still allowing pharmaceutical organizations to profit from new discoveries and innovations. The bill defines what an essential drug is, whether current prices are fair, Congress' attitude towards these prices, and the drug industry's justifications for high prices.
According to company’s CEO, William C.Weldon it is getting much harder for J&J to spot smaller firms with promising drugs and to avoid running up against other firms that want to make the same kinds of deals. Besides acquisition, Weldon believes that to accelerate top-and-bottom line growth, the company should increase the collaboration between its different units. New product can be developed by combining its strengths across pharmaceutical products, medical devices, and consumer products. The company had facing for the first time decline in revenue due to expiration of patents on some of its best selling drugs and by the growth of competition from generic drugs. This had urged the company to find new avenues for growth.
The competition of the pharmaceutical market and the management that can inflated their reported revenues by deliberately sending retailers along the distribution chanell more products than they were able to sell, could be the weakness of Biovail Corp. Biovail Corporation, was its expertise in the development and large-scale manufacturing of pharmaceutical products. It leveraged this expertise by focusing on enhanced formulations of existing drugs, combination products that incorporated two or more different therapeutic classes of drugs, and difficult to manufacture generic pharmaceuticals. Given the facts and information presented in the case, Biovail should have recognized the revenue following the FOB destination structure. However, Biovail recognized revenue as if it was operating under FOB shipping, probably in an attempt to boast revenue for the period. Under GAAP, revenue may be recognized on the sale of a product like Wellbutrin XL when, delivery of the product by the seller to the buyer has occurred.
The marketing of energy drinks, sport drinks, and vitamin-enhanced beverages targets many segments, so much so that Coke and Pepsi now own or distribute many of the labels vying against their mainstay brands. This case deals with the competition within the alternative beverage segment by exploring the strategic components, competitive forces, changes in the market, group map, and success factors. In addition this case focuses on key recommendations that will be needed to navigate the complex arena of the alternative beverage segment. Strategic Components of Alternative beverage segment The US beverage market grew by 0.9 percent in 2011 and although this marked the second year of growth for the beverage industry, after two consecutive declines in 2008 and 2009, the pace of growth slowed from 2010 (Berk, CNBC, 2012). This study emphasizes a point of a societal shift of Americans being more health conscious and not consuming as much carbonated beverages as in years past.
The legalization for pharmacological use would require the generation of jobs in the handling and growing of stable fields of a standardized potency, regulation groups, and production facilities. As with any drug on the market, tax revenues would also increase as the number of users who currently use the drug illegally would instead begin buying their medication from an authorized vendor. This would go in small part to helping relieve some of the burden of debt that the government faces allowing them to put that money towards programs in need such as education or healthcare (Seamon et al.,
The Rise In Health Care Spending And What To Do About It Abstract and Introduction Abstract Reforms for slowing the growth in health care spending and increasing the value of care have largely focused on insurance-based solutions. Consumer-driven health care represents the most recent example of this approach. However, much of the growth in health care spending over the past twenty years is linked to modifiable population risk factors such as obesity and stress. Rising disease prevalence and new medical treatments account for nearly two-thirds of the rise in spending. To be effective, reforms should focus on health promotion, public health interventions, and the cost-effective use of medical care.
Although it not always brings surprise to the fasting changing business world like new technology, it is crucial not only to the GDP and also important to everybody’s daily life by always being with consumers. It is worth to look into the retail industry in different aspects when facing the big economic depression and think of the possible future in the fasting changing business environment. The retail industry of the United States plays a leading role in the worldwide since the retailing companies that are based in the U.S. dominate on the global retailing stage and at the same time, the retail industry outweighs other industries within the States. According to the latest annual